Frontlight ResearchEarly access
Retinitis pigmentosa trials in India
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationA Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
- Where
- Cuttack
- Age
- 18 years and over
- People
- 11
- Run by
- Nanoscope Therapeutics Inc.
See details and how to joinNCT05921162